• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计的线性多表位肽免疫 HLA-A2.1/K 转基因小鼠诱导针对汉坦病毒感染的保护性 CD8 T 细胞应答。

Protective CD8 T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/K transgenic mice.

机构信息

Department of Immunology, The Fourth Military Medical University, 169 Changle West Road, Xi'an, 710032, China.

Department of Microbiology, The Fourth Military Medical University, Xi'an, 710032, China.

出版信息

Virol J. 2020 Oct 7;17(1):146. doi: 10.1186/s12985-020-01421-y.

DOI:10.1186/s12985-020-01421-y
PMID:33028368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7538842/
Abstract

BACKGROUND

An effective vaccine that prevents disease caused by hantaviruses is a global public health priority, but up to now, no vaccine has been approved for worldwide use. Therefore, novel vaccines with high prophylaxis efficacy are urgently needed.

METHODS

Herein, we designed and synthesized Hantaan virus (HTNV) linear multi-epitope peptide consisting of HLA-A*02-restricted HTNV cytotoxic T cell (CTL) epitope and pan HLA-DR-binding epitope (PADRE), and evaluated the immunogenicity, as well as effectiveness, of multi-epitope peptides in HLA-A2.1/K transgenic mice with interferon (IFN)-γ enzyme-linked immunospot assay, cytotoxic mediator detection, proliferation assay and HTNV-challenge test.

RESULTS

The results showed that a much higher frequency of specific IFN-γ-secreting CTLs, high levels of granzyme B production, and a strong proliferation capacity of specific CTLs were observed in splenocytes of mice immunized with multi-epitope peptide than in those of a single CTL epitope. Moreover, pre-immunization of multi-epitope peptide could reduce the levels of HTNV RNA loads in the liver, spleen and kidneys of mice, indicating that specific CTL responses induced by multi-epitope peptide could reduce HTNV RNA loads in vivo.

CONCLUSIONS

This study may provide an important foundation for the development of novel peptide vaccines for HTNV prophylaxis.

摘要

背景

一种能够预防汉坦病毒引起的疾病的有效疫苗是全球公共卫生的当务之急,但迄今为止,还没有一种疫苗获得全球批准使用。因此,迫切需要具有高预防效果的新型疫苗。

方法

在此,我们设计并合成了汉坦病毒(HTNV)线性多表位肽,由 HLA-A*02 限制性 HTNV 细胞毒性 T 细胞(CTL)表位和泛 HLA-DR 结合表位(PADRE)组成,并通过 IFN-γ 酶联免疫斑点试验、细胞毒性介质检测、增殖试验和 HTNV 挑战试验评估了多表位肽在 IFN-γ 酶联免疫斑点试验、细胞毒性介质检测、增殖试验和 HTNV 挑战试验中的免疫原性和有效性。

结果

结果表明,与单一 CTL 表位相比,多表位肽免疫的小鼠脾细胞中特异性 IFN-γ 分泌 CTL 的频率更高,颗粒酶 B 产生水平更高,特异性 CTL 的增殖能力更强。此外,多表位肽的预免疫可以降低 HTNV RNA 在小鼠肝脏、脾脏和肾脏中的载量,表明多表位肽诱导的特异性 CTL 反应可以减少体内 HTNV RNA 的载量。

结论

本研究可能为开发新型 HTNV 预防肽疫苗提供重要基础。

相似文献

1
Protective CD8 T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/K transgenic mice.设计的线性多表位肽免疫 HLA-A2.1/K 转基因小鼠诱导针对汉坦病毒感染的保护性 CD8 T 细胞应答。
Virol J. 2020 Oct 7;17(1):146. doi: 10.1186/s12985-020-01421-y.
2
Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8 T cells.设计并合成 HLA-A*02 限制性汉坦病毒多表位肽以刺激 CD8 T 细胞。
Virol J. 2020 Jan 31;17(1):15. doi: 10.1186/s12985-020-1290-x.
3
Screening and Identification of an H-2K-Restricted CTL Epitope within the Glycoprotein of Hantaan Virus.汉坦病毒糖蛋白中H-2K限制性CTL表位的筛选与鉴定
Front Cell Infect Microbiol. 2016 Nov 25;6:151. doi: 10.3389/fcimb.2016.00151. eCollection 2016.
4
HLA-A2 and B35 restricted hantaan virus nucleoprotein CD8+ T-cell epitope-specific immune response correlates with milder disease in hemorrhagic fever with renal syndrome.HLA-A2 和 B35 限制性汉坦病毒核蛋白 CD8+ T 细胞表位特异性免疫反应与肾综合征出血热的轻症相关。
PLoS Negl Trop Dis. 2013;7(2):e2076. doi: 10.1371/journal.pntd.0002076. Epub 2013 Feb 28.
5
Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/K Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.新鉴定出的汉坦病毒糖蛋白HLA-A*0201限制性细胞毒性T细胞表位可有效诱导HLA-A2.1/K转基因小鼠产生保护性反应,可能与肾综合征出血热的严重程度相关。
Front Immunol. 2017 Dec 12;8:1797. doi: 10.3389/fimmu.2017.01797. eCollection 2017.
6
Characterization of HLA-A2.1-restricted epitopes, conserved in both Hantaan and Sin Nombre viruses, in Hantaan virus-infected patients.在感染汉坦病毒的患者中,对在汉滩病毒和辛诺柏病毒中均保守的HLA - A2.1限制性表位进行鉴定。
J Gen Virol. 2002 May;83(Pt 5):1131-1136. doi: 10.1099/0022-1317-83-5-1131.
7
Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.介导HLA - A2.1/K(b)转基因小鼠有效保护性反应的汉坦病毒细胞毒性T细胞表位的HLA - A*02限制性结构与功能
Front Immunol. 2016 Aug 8;7:298. doi: 10.3389/fimmu.2016.00298. eCollection 2016.
8
Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.在转基因HLA - A2小鼠中用Th - CTL融合肽和胞嘧啶 - 磷酸 - 鸟嘌呤DNA进行免疫接种可诱导对HIV感染的T细胞的识别并清除痘苗病毒攻击。
J Immunol. 2003 Oct 15;171(8):4028-39. doi: 10.4049/jimmunol.171.8.4028.
9
Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.一种在 HLA 转基因小鼠中具有抗巨细胞病毒 pp65 活性的无佐剂肽疫苗的临床前开发。
Blood. 2002 Nov 15;100(10):3681-9. doi: 10.1182/blood-2002-03-0926. Epub 2002 Jul 12.
10
Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.鉴定乙型肝炎病毒核心蛋白中 HLA-A*0201 限制性 CD8+ T 细胞表位 C₆₄₋₇₂。
Int Immunopharmacol. 2012 Jun;13(2):141-7. doi: 10.1016/j.intimp.2012.03.018. Epub 2012 Apr 3.

引用本文的文献

1
Hantaan virus infection induces human mucosal-associated invariant T cell pyroptosis through IRE1α pathway.汉坦病毒感染通过IRE1α途径诱导人黏膜相关恒定T细胞焦亡。
Commun Biol. 2025 Apr 1;8(1):538. doi: 10.1038/s42003-025-07979-z.
2
Designing a Conserved Immunogenic Peptide Construct from the Nucleocapsid Protein of .设计来自.核衣壳蛋白的保守免疫原性肽结构。
Viruses. 2024 Jun 26;16(7):1030. doi: 10.3390/v16071030.
3
Integrating immunoinformatics and computational epitope prediction for a vaccine candidate against respiratory syncytial virus.

本文引用的文献

1
: Current Classification and Future Perspectives.当前分类与未来展望
Viruses. 2019 Aug 27;11(9):788. doi: 10.3390/v11090788.
2
Progress on the Prevention and Treatment of Hantavirus Disease.汉坦病毒病防治进展。
Viruses. 2019 Jul 4;11(7):610. doi: 10.3390/v11070610.
3
T-Cell Response to Viral Hemorrhagic Fevers.T细胞对病毒性出血热的反应。
整合免疫信息学与计算表位预测以研发针对呼吸道合胞病毒的候选疫苗
Infect Dis Model. 2024 Apr 16;9(3):763-774. doi: 10.1016/j.idm.2024.04.005. eCollection 2024 Sep.
4
The Adaptive Immune Response against .针对 的适应性免疫反应。
Viruses. 2024 Mar 21;16(3):483. doi: 10.3390/v16030483.
5
Vaccination-Route-Dependent Adjuvanticity of Antigen-Carrying Nanoparticles for Enhanced Vaccine Efficacy.携带抗原的纳米颗粒的疫苗接种途径依赖性佐剂效应可增强疫苗效力。
Vaccines (Basel). 2024 Jan 26;12(2):125. doi: 10.3390/vaccines12020125.
6
Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses.高致病性布尼亚病毒疫苗研发的进展与展望。
Front Cell Infect Microbiol. 2023 May 18;13:1174030. doi: 10.3389/fcimb.2023.1174030. eCollection 2023.
7
Correlation analysis of CD8 cell overexpression and prognosis of hemorrhagic fever with renal syndrome-a case-control study.肾综合征出血热CD8细胞过表达与预后的相关性分析——一项病例对照研究
Front Pediatr. 2023 May 5;11:1168205. doi: 10.3389/fped.2023.1168205. eCollection 2023.
8
IL-15 induced bystander activation of CD8 T cells may mediate endothelium injury through NKG2D in Hantaan virus infection.汉坦病毒感染中,IL-15 诱导的 CD8 T 细胞旁观者激活可能通过 NKG2D 介导内皮细胞损伤。
Front Cell Infect Microbiol. 2022 Dec 15;12:1084841. doi: 10.3389/fcimb.2022.1084841. eCollection 2022.
9
Comparative Immunoreactivity Analyses of Hantaan Virus Glycoprotein-Derived MHC-I Epitopes in Vaccination.汉坦病毒糖蛋白衍生的MHC-I表位在疫苗接种中的比较免疫反应性分析
Vaccines (Basel). 2022 Apr 6;10(4):564. doi: 10.3390/vaccines10040564.
10
Immunogenic Properties of MVs Containing Structural Hantaviral Proteins: An Original Study.含有汉坦病毒结构蛋白的微小病毒样颗粒的免疫原性特性:一项原创研究。
Pharmaceutics. 2022 Jan 1;14(1):93. doi: 10.3390/pharmaceutics14010093.
Vaccines (Basel). 2019 Jan 22;7(1):11. doi: 10.3390/vaccines7010011.
4
Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome.灭活汉坦病毒疫苗对肾综合征出血热疾病严重程度的有效性。
Kidney Res Clin Pract. 2018 Dec;37(4):366-372. doi: 10.23876/j.krcp.18.0044. Epub 2018 Dec 31.
5
Spatiotemporal variation of the association between climate dynamics and HFRS outbreaks in Eastern China during 2005-2016 and its geographic determinants.2005-2016 年期间中国东部地区气候动态与 HFRS 疫情的时空变化及其地理决定因素。
PLoS Negl Trop Dis. 2018 Jun 6;12(6):e0006554. doi: 10.1371/journal.pntd.0006554. eCollection 2018 Jun.
6
Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/K Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.新鉴定出的汉坦病毒糖蛋白HLA-A*0201限制性细胞毒性T细胞表位可有效诱导HLA-A2.1/K转基因小鼠产生保护性反应,可能与肾综合征出血热的严重程度相关。
Front Immunol. 2017 Dec 12;8:1797. doi: 10.3389/fimmu.2017.01797. eCollection 2017.
7
Personalized peptide vaccines and their relation to other therapies in urological cancer.个性化肽疫苗及其与泌尿癌症其他疗法的关系。
Nat Rev Urol. 2017 Aug;14(8):501-510. doi: 10.1038/nrurol.2017.77. Epub 2017 May 31.
8
Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.介导HLA - A2.1/K(b)转基因小鼠有效保护性反应的汉坦病毒细胞毒性T细胞表位的HLA - A*02限制性结构与功能
Front Immunol. 2016 Aug 8;7:298. doi: 10.3389/fimmu.2016.00298. eCollection 2016.
9
Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture.肾综合征出血热:发病机制与临床表现
Front Cell Infect Microbiol. 2016 Feb 3;6:1. doi: 10.3389/fcimb.2016.00001. eCollection 2016.
10
CD8low CD100- T Cells Identify a Novel CD8 T Cell Subset Associated with Viral Control during Human Hantaan Virus Infection.CD8低表达CD100阴性T细胞鉴定出一种与人类汉坦病毒感染期间病毒控制相关的新型CD8 T细胞亚群。
J Virol. 2015 Dec;89(23):11834-44. doi: 10.1128/JVI.01610-15. Epub 2015 Sep 16.